Chicago Elite
Jennifer Greenblatt at Goldman Ismail Tomaselli Brennan & Baum LLP handles complex commercial, product liability, and antitrust disputes for national clients across industries including healthcare, life sciences, education, and broader commercial sectors. Greenblatt’s work spans high-stakes litigation nationwide, focusing on Fortune 500 companies with cases valued in the billions.
Legal 500 Editorial commentary
Accolades
Chicago Elite
Mentions
Dispute resolution
Commercial disputes – boutique firms
Dispute resolution
General commercial disputes - premium ($500m+)
Dispute resolution
Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Dispute resolution
Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Next Generation PartnersProfile
Work Department
Litigation
Position
- Partner, Goldman Ismail Tomaselli Brennan & Baum LLP
Memberships
- Board Member, Law360 Competition Editorial Advisory Board
- Board Member, Law360 Product Liability Editorial Advisory Board
- Board Member, Emory Law Institute for Complex Litigation and Mass Claims Emerging Leaders Advisory Board
- Advisory Counsel Member, Rabiej Litigation Law Center
- Member, International Association of Defense Counsel (IADC)
- Senior Fellow, Litigation Counsel of America (LCA)
Education
- Stanford Law School (J.D., with distinction)
- Stanford Law Review, Notes Editor and Senior Editor
- Stanford Law and Policy Review, Associate Editor for health care symposium and Personnel Manager
- Criminal Prosecution Clinic
- Cornell University (B.S., with distinction)
- Valedictorian
Content supplied by Goldman Ismail Tomaselli Brennan & Baum LLP
Key clients
- Merck & Co., Inc.; Merck Sharp & Dohme LLC; Schering-Plough Corp.; Schering Corp.; and MSP Singapore Co. LLC
- Lafarge North America Inc.; Lafarge Building Materials Inc.
Work highlights
Represented Merck & Co., Inc in a class action and opt-out lawsuit against Zetia Hatch-Waxman.